By targeting ING5, miR-27-3p promotes the G1-S phase transition in osteosarcoma cells (Ye et al., 2018) and miR-196b-5p inhibits the apoptosis of pancreatic cancer cells (Ma et al., 2021). This evidence concerns the gene ING5 and familial pancreatic carcinoma.